Zantac & Ranitidine

/Zantac & Ranitidine

Sanofi recalls Zantac OTC due to chemical contamination that may cause cancer

Sanofi has announced that it is recalling the popular heartburn drug Zantac OTC. The drugmaker made the announcement following tests that found that Zantac was contaminated with a chemical impurity that can increase the risk of cancer. (more…)

By | 2019-10-25T16:06:30+00:00 October 25th, 2019|Zantac & Ranitidine|Comments Off on Sanofi recalls Zantac OTC due to chemical contamination that may cause cancer

Zantac and ranitidine contaminated with cancer-causing chemical, FDA says

An investigation by the U.S. Food and Drug Administration has found that the heartburn drug Zantac and some generic versions of the drug are contaminated with a chemical that may cause cancer. Several national pharmacy chains have pulled Zantac and generic ranitidine from their shelves over concerns that patients who use these medications may face an increased cancer risk. (more…)

By | 2019-10-17T20:52:19+00:00 October 14th, 2019|Zantac & Ranitidine|Comments Off on Zantac and ranitidine contaminated with cancer-causing chemical, FDA says